Illumina, Inc.
ILMNNASDAQHealthcareDiagnostics & Research
As of Oct 23, 2026 close
- Market cap
- $41.22B
- P/E (TTM)
- 49.97
- Forward P/E
- 76.56
- Dividend yield
- -
- 52-week range
- $94.00$309.35
- Volume (live)
- -
- Avg. volume (3M)
- 3.71M
Illumina (ILMN) Stock Price & Financial Analysis
Illumina Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $264.42 - $271.64 |
|---|---|
| 52-Week High | $309.35 |
| 52-Week Low | $94.00 |
| Open | $264.42 |
| Volume (last close) | 1.26M |
| Average Volume (3M) | 3.71M |
| Revenue (TTM) | 4.49B |
|---|---|
| Net Income (TTM) | 825.00M |
| Free Cash Flow (TTM) | 938.00M |
| EPS (TTM) | $5.37 |
| Profit Margin | 18.37% |
| Operating Margin | 19.95% |
| Return on Equity (ROE) | 29.07% |
| Debt to Equity | 0.89 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 41.22B |
|---|---|
| Shares Outstanding | 153.00M |
| P/E Ratio (TTM) | 49.97 |
| Forward P/E | 76.56 |
| Price to Sales (P/S) | 9.18 |
| Price to Book (P/B) | 14.52 |
| EV/EBITDA | 31.38 |
| 50-Day MA | $236.94 |
|---|---|
| 200-Day MA | $170.98 |
| 1-Year Change | +169.48% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Illumina at a Glance
As of the Oct 23, 2026 close, Illumina (ILMN) has a market capitalization of $41.22B. The stock trades at 50.0× trailing earnings, 76.6× forward earnings and 9.2× sales. Over the trailing twelve months it earned $825.00M on revenue of $4.49B (a 18.4% profit margin) and generated $938.00M of free cash flow. Revenue grew 4.9% year over year.
As of its latest reported balance sheet, it holds $1.04B in cash and securities against $2.53B of debt, a net debt position of $1.49B.
Illumina does not currently pay a dividend.
The share price is up 169.5% over the past year. At $269.42 (the Oct 23, 2026 close) it sits within its 52-week range of $94.00 to $309.35, above its 200-day moving average of $170.98.
Based on 19 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $249.13, 7.5% below the Oct 23, 2026 close.
Frequently Asked Questions About Illumina
What is the current stock price for ILMN?
As of the Oct 23, 2026 close, ILMN stock trades at $269.42. The 52-week range is $94.00–$309.35, with a day range of $264.42–$271.64.
What is the P/E ratio for ILMN?
As of the Oct 23, 2026 close, Illumina's trailing twelve-month (TTM) P/E ratio is 50.0, meaning investors pay $50.0 for every $1 of annual earnings. The forward P/E is 76.6, reflecting analyst expectations for future earnings. Illumina operates in the Healthcare sector.
Does ILMN pay dividends?
Illumina does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for ILMN?
Based on ratings from 19 professional analysts over the last 90 days, the consensus for ILMN is Buy. The average 12-month price target is $249.13, a 7.5% downside from the Oct 23, 2026 close of $269.42.
What is the market cap of ILMN?
As of the Oct 23, 2026 close, Illumina's market capitalization is $41.22B, classifying it as a large-cap company. Illumina operates in the Healthcare sector within the Diagnostics & Research industry.